Find Enramycin Premix For Growth Promotion, Enramycin Premix 4% For Animal, Enramycin Premix 8% For Animal on Industry Directory, Reliable Manufacturer/Supplier/Factory from China.

Inquiry Basket (0)
Home > Products > Animal Feed > Enramycin Premix for Animal Feed

Enramycin Premix for Animal Feed

  • Enramycin Premix for Animal Feed
  • Enramycin Premix for Animal Feed
  • Enramycin Premix for Animal Feed

Enramycin Premix for Animal Feed

    Payment Type: L/C,T/T,D/P,Paypal,Money Gram,Western Union
    Terms of Trade: FOB,CFR,CIF,EXW,FCA,CPT,CIP
    Min. Order: 100 Kilogram
    Transportation: Ocean,Land,Air
    Port: Qingdao,Shanghai,Beijing

Basic Info

Model No.: ENP02

Product Description

Enramycin Premix

Good Growth Promotion, and High Feed Return.

[Main Component]



This product is grey, or grey brown Powder, with special odor.

[Pharmacological Action]


Enramycin belongs to polypeptide antibiotics. And it has strong killing effect towards gram-positive bacterium. And its main mechanism is to control bacterial cell wall synthesis. It has high antibacterial activity to those which is harmful to intestine, such as clostridium, streptococcus, staphylococcus, etc. And Enramycin has low or barely no antibacterial activity to gram-negative bacteria.


For oral administration, Enramycin is barely absorbed,or absorbed by animal. It would not be disintegrated by digestive enzyme, then excreted to the outside of the body.

[Effect and function]

Precaution for swine and poultry gram-positive bacterium infection, and growth promoters for swine and poultry.

[Usage and dosage]

Calculated based on Enramycin.

Mixed in feedstuff: every 1000kg feed, 2.5~20g for swine; 1~5g for chicken.

[Side effect]

According to the prescribed usage and dosage, no adverse reactions have been observed.


(1) Forbidden to use on egg chicken during egg producing period.

(2) Incompatibility: Forbidden to use together with Kitasamycin, Bacitracin zinc and Virginiamycin.

[Withdrawal period]

7 days for swine and chicken.


4%, 8%




Keep airtight and shading in a dry place at room temperature.


2 years.

Shandong Shengli Bioengineering Co., Ltd

 Shandong Shengli Bioengineering Co., Ltd (Abbreviation: SHENGLI) is a joint venture built by China Animal Husbandry Industry Company Limited (Abbreviation: CAHIC) and Shandong Shengli Corporation Limited. And originally built in 2004 with total investment of RMB 500 million, and guided by bio-fermentation technology, producing animal-specific antibiotic API, veterinary preparations and feed additives. Also, it is national high-tech enterprise, and regarded as top 10 veterinary drug enterprise in Shandong province and top 10 in national veterinary drug industry in China. Shengli is located in No.118, High-tech zone, Jining city, Shandong province, China. And it has covered an area of 70 acres, and equipped with 1st class facility as well as advanced management. Currently Shengli primarily manufactures feed additives, such as Enramycin, Bambermycin, Hainanmycin, Nosiheptide, Monensin and Salinomycin, also veterinary drugs as Tiamulin Fumarate, Florfenicol, Tilmicosin, Doxycycline Hydrochloride, etc. And Shengli is global leader on Tiamulin Fumarate and Bambermycin production and sales, also the professional manufacturer in the globe that own China self-owned intellectual property on Hainanmycin sodium API & Premix. Shengli possesses complete veterinary drug workshop and production line that passes US FDA and CHINA GMP authentication, and there are production equipments of first-rate and high level automation that manufacture various animal-specific drugs. In strict accordance with current GMP standard in EU and USA, we have been establishing and improving quality control system, and our product have been registered and authenticated in dozens of countries and areas overseas. Among all products, Tiamulin Fumarate API has been awarded EU COS certificate in the lead; Tiamulin Fumarate Premix 80% have required Japan FMA certificate; Premix of Tiamulin Fumarate and that of Bambermycin, Monensin, Salinomycin have achieved Australia APVMA authentication. And we possess self-owned intellectual property patent in China concerning Enramycin and Avilamycin, and our products are sold well both at home and abroad. Shengli values research and re-innovation on technology import, and set up Cahic-Shengli R&D Institute, and Shengli has required many national patent and scientific achievements while positively establishing cooperation with peers and professionals domestic and overseas. Shengli always adhere to the management principle of [Success on quality, Sharing on profit, and all win on prosperity". We stick to contract-honoring and promise-keeping, with high brand reputation, and have built well-rounded marketing network domestic and overseas. Sincerely hope to establish new type of friendly relations and mutual development cooperation with clients.

Company Info

  • Company Name: Shandong Shengli Bioengineering Co., Ltd
  • Representative: Zhang Zhenghai
  • Product/Service: Tiamulin Fumarate , Tylvalosin Tartrate , Florfenicol Powder , Spectinomycin And Lincomycin , Hainanmycin Sodium , Doxycycline Hyclate Soluble Powder
  • Capital (Million US $): 200000000RMB
  • Year Established: 2004
  • Total Annual Sales Volume (Million US $): US$50 Million - US$100 Million
  • Export Percentage: 51% - 60%
  • Total Annual Purchase Volume (Million US $): Below US$1 Million
  • No. of Production Lines: 10
  • No. of R&D Staff: 51 -60 People
  • No. of QC Staff: 51 -60 People
  • OEM Services Provided: yes
  • Factory Size (Sq.meters): 30,000-50,000 square meters
  • Factory Location: No.118, Tongji Road, High-tech Zone, Jining, Shandong, China
  • Contact Person: Ms. Sun
  • Tel: 86-537-2481087
Email to this supplier
  • *Subject:
  • To:

  • *Messages:
    Your message must be between 20-8000 characters